$Sub-groups of anti-osteoporosis drug users, and associated fracture risk in real world primary care settings: a data-driven cluster analysis$

Sub-groups of anti-osteoporosis drug users, and associated fracture risk in real world primary care settings: a data-driven cluster analysis

Detalhes bibliográficos
Principais autores:	Khalid, S, Ali, MS, Silman, A, Prieto-Alhambra, D
Formato:	Conference item
Publicado em:	Wiley 2017

Registros relacionados

Characterising anti-osteoporosis drug users in real world primary care settings in Spain: A data-driven cluster analysis
por: Khalid, S, et al.
Publicado em: (2017)

Data-driven cluster analysis for identifying groups within users of anti-osteoporosis medication, using real-world primary care data.
por: Khalid, S, et al.
Publicado em: (2017)

Comparative anti-fracture effectiveness of different anti-osteoporosis medications amongst male drug users in real world clinical practice: a population-based cohort study
por: Zwart, M, et al.
Publicado em: (2016)

Deep learning to detect features of a population of anti-osteoporosis drug users
por: Khalid, S, et al.
Publicado em: (2018)

[Degenerative osteoarthritis, osteoporosis and fractures: controversies and evidences].
por: Pagès-Castellà, A, et al.
Publicado em: (2013)

Epidemiology of Osteoporotic Fractures in Europe: towards biologic mechanisms. The European Prospective Osteoporosis Study Group.
por: Reeve, J, et al.
Publicado em: (1997)

Deep learning for drug utilisation research: Identifying features within a population of anti-osteoporosis drug users
por: Khalid, S, et al.
Publicado em: (2018)

Comparative fracture risk amongst users of different anti-osteoporosis drugs available in the UK in the NHS: A propensity-matched cohort study using data from the Clinical Practice Research Datalink
por: Khalid, S, et al.
Publicado em: (2016)

Comparative anti-fracture effectiveness of different oral anti-osteoporosis therapies based on “real-world” data: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database
por: Khalid S, et al.
Publicado em: (2018-10-01)

Comparative anti-fracture effectiveness of different oral anti-osteoporosis therapies based on “real-world” data: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database
por: Khalid, S, et al.
Publicado em: (2018)

Fracture risk following intermission of osteoporosis therapy
por: Dennison, EM, et al.
Publicado em: (2019)

Rib fractures predict incident limb fracture: Results from the European Prospective Osteoporosis Study.
por: Ismail, A, et al.
Publicado em: (2004)

Rib fractures predict incident limb fractures: results from the European prospective osteoporosis study.
por: Ismail, A, et al.
Publicado em: (2006)

Childhood fractures do not predict future fractures: results from the European Prospective Osteoporosis Study.
por: Pye, SR, et al.
Publicado em: (2009)

Fractures in users of antidepressants and anxiolytics and sedatives: effects of age and dose
por: Vestergaard, P, et al.
Publicado em: (2013)

Fractures in users of antidepressants and anxiolytics and sedatives: effects of age and dose.
por: Vestergaard, P, et al.
Publicado em: (2013)

Fractures in users of antidepressants and anxiolytics and sedatives effects of age and dose
por: Vestergaard, P, et al.
Publicado em: (2012)

Comparative fracture risk amongst users of different anti-osteoporosis therapies: meta-analysis of propensity-matched cohort studies using data from the Clinical Practice Research Datalink (UK) and SIDIAP (Spain).
por: Khalid, S, et al.
Publicado em: (2017)

Childhood fractures do not predict future fractures: Results from the European Prospective Osteoporosis Study (EPOS)
por: Pye, SR, et al.
Publicado em: (2007)

One- and 2-year incidence of osteoporotic fracture: a multi-cohort observational study using routinely collected real-world data
por: Khalid, S, et al.
Publicado em: (2021)

Curator – a data curation tool for clinical real-world evidence
por: Delmestri, A, et al.
Publicado em: (2023)

Curator – A data curation tool for clinical real-world evidence
por: Antonella Delmestri, et al.
Publicado em: (2023-01-01)

Reduction in fracture rates with Denosumab compared to Alendronate in treatment naïve patients: a propensity-matched ‘real world’ cohort and instrumental variable analysis.
por: Khalid, S, et al.
Publicado em: (2017)

Prevalence of vertebral fracture and densitometric osteoporosis in Spanish adult men: The Camargo Cohort Study
por: Olmos, J, et al.
Publicado em: (2017)

Machine learning for feature selection and cluster analysis in drug utilisation research
por: Khalid, S, et al.
Publicado em: (2019)

Imminent fracture risk amongst new users of oral bisphosphonates in actual practice settings: A multi-national European cohort study from Denmark, Spain, and the UK
por: Khalid, S, et al.
Publicado em: (2019)

The impact of rheumatoid arthritis on the risk of adverse events following joint replacement: a real-world cohort study
por: Burn, E, et al.
Publicado em: (2018)

The impact of rheumatoid arthritis on the risk of adverse events following joint replacement: a real-world cohort study
por: Burn E, et al.
Publicado em: (2018-06-01)

Comparative risk of venous thromboembolism amongst users of different anti-osteoporosis drugs in the uk: a propensity-matched cohort study using data from the clinical practice research datalink
por: Khalid, S, et al.
Publicado em: (2016)

Treatment patterns for osteoporosis medications in five European countries: a multinational real world cohort analysis
por: Robinson, DE, et al.
Publicado em: (2022)

Teriparatide in East Asian Postmenopausal Women with Osteoporosis in a Real-World Setting: A Baseline Analysis of the Asia and Latin America Fracture Observational Study (ALAFOS)
por: Chen CH, et al.
Publicado em: (2020-01-01)

Machine learning for risk factor identification and cardiovascular mortality prediction among patients with osteoporosis
por: Hasheminasab, AH, et al.
Publicado em: (2023)

Artrosis, osteoporosis y fracturas: controversias y evidencias
por: Pagès-Castellà, A, et al.
Publicado em: (2013)

Two-fold regional variation in initiation of anti-osteoporosis medication after hip fracture in the UK
por: Shah, A, et al.
Publicado em: (2016)

Two-fold regional variation in initiation of anti-osteoporosis medication after hip fracture in the UK
por: Shah, A, et al.
Publicado em: (2016)

Real-world treatment and fracture incidence in postmenopausal women with severe osteoporosis at high risk of fracture: a retrospective claims data analysis
por: Mevius, Antje, et al.
Publicado em: (2021-12-01)

The association between keloid and osteoporosis: real-world evidence
por: Chun-Ching Lu, et al.
Publicado em: (2021-01-01)

Anti-osteoporosis medication prescriptions and incidence of secondary fracture amongst hip fracture patients in England and Wales: an age stratified interrupted time series analysis
por: Hawley, S, et al.
Publicado em: (2018)

Risk of osteoporotic fractures in new users of denosumab compared with new users of alendronate: A Danish populationbased cohort study
por: Pedersen, AB, et al.
Publicado em: (2018)

Anti-osteoporosis medication prescriptions and incidence of subsequent fracture among primary hip fracture patients in England and Wales: an interrupted time-series analysis
por: Hawley, S, et al.
Publicado em: (2016)